Jakob Loven Net Worth & Insider Trades

Jakob Loven - Director, Kronos Bio, Inc

As of April 20, 2021

What is Jakob Loven's Net Worth?

The current estimated net worth of Kronos Bio, Inc's Director, Jakob Loven, is estimated to be about $57.02M . Jakob Loven owns about 1,301,537 units of Kronos Bio, Inc common stock. In the last year at Kronos Bio, Inc, Jakob Loven has sold an estimated value of $5.84M worth.

What is Jakob Loven's Past Insider Trading?

Jakob Loven's largest sale order was 100,616 units , worth over $2.74M on April 12, 2021. In total, Jakob Loven has made about 4 transactions over a year of their time at Kronos Bio, Inc. Jakob Loven usually trades in April, with the busiest year in 2021. The most recent transaction was a sale order of 68,717 units , worth over $1.42M on April 20, 2021.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jakob Loven

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Jakob Loven's' Mailing Address?

  • Mailing address is C/o Arvinas, Inc., 5 Science Park 395 Winchester Avenue New Haven CT 06511 CT

What are Kronos Bio, Inc's Past Insider Trades?

Kronos Bio, Inc's most recent insider trade came on July 7, 2023 by Christopher Dinsmore who sold 6,634 units worth $11.62K . In the last 3 years, insiders at Kronos Bio, Inc have sold an estimated value of $6.91M and bought an estimated value of $53.65M worth of shares. Insider trading is most common in June, with the busiest year in 2023 and 2021. The most active traders at the company are Christopher Dinsmore, Chief Scientific Officer,  Jorge Dimartino, Chief Medical Officer & VP,  and Marianne Backer de, Director .

Kronos Bio, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...